Sampre Nutritions Limited (SNL) has entered into a significant manufacturing agreement with Reliance Consumer Products Limited (RCPL), marking a notable development in the nutraceutical and food products sector. The deal, signed on October 8, 2025, is expected to boost Sampre Nutritions' revenue stream over the next three years.

Key Details of the Agreement

Terms and Conditions

Under the agreement, Sampre Nutritions will manufacture, pack, and supply confectionery, nutraceutical, and food products to RCPL. The production will adhere to RCPL's specifications and quality standards. Key points of the agreement include:

1. Pricing: Determined by RCPL based on the agreement's pricing mechanism
2. Payments: Made upon delivery of finished goods
3. Quality Control: Products to meet RCPL's prescribed specifications and standards
4. Ownership: Title and risk of goods remain with SNL until acceptance by RCPL at the designated delivery location

Impact and Implications

This agreement is expected to contribute significantly to Sampre Nutritions' revenues, potentially boosting its operations in the nutraceutical and food product segments. The deal aligns with the company's growth strategy and may enhance its market position in the confectionery and nutraceutical sectors.

Corporate Governance Aspects

It's worth noting that this agreement does not fall under related party transactions. As of the agreement date, there is no shareholding between the two companies, and neither party is related to the other's promoter groups. This transparency in corporate dealings underscores the arm's length nature of the transaction.

The manufacturing agreement between Sampre Nutritions and Reliance Consumer Products represents a strategic move in the competitive nutraceutical and food products industry. As the partnership unfolds over the next three years, it will be interesting to observe its impact on Sampre Nutritions' financial performance and market standing.

Sampre Nutritions Limited, a prominent player in the FMCG sector, has taken a significant step towards international expansion by approving the issuance of Foreign Currency Convertible Bonds (FCCBs) worth USD 40 million. This move is part of a larger USD 100 million FCCB program aimed at strengthening the company's global presence, particularly in high-growth regions such as Egypt and Liberia.

FCCB Issuance Details

The Board of Directors of Sampre Nutritions Limited has approved the issuance of 400 FCCBs, each with a par value of USD 100,000. The bonds will be offered at a 15% discount, with an offering price of USD 85,000 per bond. Key features of the FCCB issuance include:

Conversion and Utilization of Funds

The FCCBs can be converted to equity shares at the bondholders' discretion, with the following conditions:

• Conversion window: Any time after one week from issuance until maturity
• Conversion price: To be determined as per SEBI guidelines

The funds raised through this FCCB issuance will be primarily utilized for Sampre Nutritions' global expansion strategy, focusing on:

1. Establishing a presence in Egypt
2. Expanding operations in Liberia (Monrovia)

These strategic moves are designed to strengthen the company's foothold in high-growth regions, diversify revenue streams, and capitalize on emerging opportunities in the international FMCG sectors.

Strategic Decisions and Future Outlook

In light of this FCCB issuance, Sampre Nutritions has made some notable decisions:

1. Postponement of Preferential Allotment: The company has decided to postpone a previously planned preferential allotment of securities.

2. Focus on International Markets: By targeting Egypt and Liberia, Sampre Nutritions aims to broaden its global footprint and tap into new market opportunities.

3. Long-term Growth Strategy: This move aligns with the company's vision to strengthen its presence in high-growth regions and diversify its revenue streams in the international FMCG sector.

The Board meeting that approved these decisions was held on October 3, 2025, commencing at 2:00 P.M. (IST) and concluding at 5:00 P.M. (IST).

Sampre Nutritions Limited's strategic decision to issue FCCBs and expand globally reflects the company's ambition to capitalize on international growth opportunities and enhance its position in the competitive FMCG market. As the company embarks on this new phase of expansion, investors and industry observers will be keenly watching the impact of these moves on Sampre Nutritions' future growth and market position.